Amend Surgical
PrivateLast Round
Grant
May 4, 2022
Total Funding Raised
$500,000
Company Overview
Amend Surgical operates in Healthcare & Life Sciences and is based in Alachua, Florida. Its latest recorded funding round was a Grant round in May 2022.
Amend Surgical is a medical device company that develops and manufactures novel orthobiologics and biomaterials to enhance bone healing and wound closure for the orthopedic, spine, and dental surgery fields.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amend Surgical Comparables
Compare Amend Surgical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synergy Biomedical, LLC | 85% | |
| RevBio, Inc. | 83% | |
| Acuitive Technologies Inc. | 80% |
For institutional investors. Book with your work email.
Amend Surgical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 4, 2022 | ||||
| Grant | May 18, 2017 | ||||
| Seed | Apr 15, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amend Surgical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institute for Commercialization of Florida Technology | Grant |
| Translational Resource Center | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 75% MoM, from 1.1K to 1.9K.
- May 2, 2025
Monthly visitors increased 75% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 10, 2026
Amend Surgical continues developing NanoFUSE(R) Bioactive Plug under an exclusive worldwide license from MLM Biologics, with the product designed to stimulate bone growth and reduce complications after tooth extractions.
- partners_withAug 10, 2026
On Aug 10th '26 in Florida, Amend Surgical partners with MLM Biologics Inc. through an exclusive worldwide licensing agreement to advance NanoFUSE(R) Bioactive Plug development, with exclusive rights to collagen technology for dental applications.
For institutional investors. Book with your work email.
Amend Surgical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amend Surgical's valuation, stock price, and market status.
Is Amend Surgical a public or private company?
Amend Surgical is a private company.
What is the current stock price of Amend Surgical?
Amend Surgical is a private company, so its shares have no public market price. Caplight tracks Amend Surgical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amend Surgical worth (valuation)?
Valuation information for Amend Surgical is not publicly available.
Can I buy Amend Surgical stock?
Amend Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amend Surgical's last funding round?
Amend Surgical's most recent funding round was Grant on May 4, 2022.
Who are the main investors in Amend Surgical?
Key investors in Amend Surgical include Institute for Commercialization of Florida Technology, Translational Resource Center.
Will Amend Surgical IPO soon?
No public IPO plans have been announced for Amend Surgical.
How can I track Amend Surgical secondary market activity?
Caplight tracks bids, offers, and trades in Amend Surgical's shares on secondary markets.